causal
Analysis v1
Strong Support
A drug called Evolocumab helps lower the chance of serious heart problems like heart attacks and strokes in people at high risk — and it seems to work pretty well over about 8 months.
59
0
Evidence from Studies
Supporting (1)
59
Community contributions welcome
59
Proprotein convertase subtilisn/kexin type 9 inhibitors and small interfering RNA therapy for cardiovascular risk reduction: A systematic review and meta-analysis
Systematic Review With Meta-Analysis
Human
2023The study looked at the same drug, Evolocumab, in similar patients and found it reduced heart problems by exactly the amount claimed.
Contradicting (0)
0
Community contributions welcome
No contradicting evidence found
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.